Jim Simons Ionis Pharmaceuticals Inc Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 190,514 shares of IONS stock, worth $6.87 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
190,514
Previous 249,514
23.65%
Holding current value
$6.87 Million
Previous $11.9 Million
35.83%
% of portfolio
0.01%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$543 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$511 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$372 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$315 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$284 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.12B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...